Charis E. Teh
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Repurposing BH3 mimetics to deplete tumour-infiltrating regulatory T cells and enhance anti-tumour immunity in non-small cell lung cancer.
Journal: Cell death and differentiation
Published: December 09, 2025
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: October 26, 2025
The NF-κB transcription factor RelA directs mucosal-associated invariant T-cell development.
Journal: Immunology and cell biology
Published: June 06, 2025
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.
Journal: PLoS pathogens
Published: May 12, 2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer.
Journal: Blood advances
Published: January 30, 2025
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.
Journal: Nature immunology
Published: December 12, 2023
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers.
Journal: Nature cell biology
Published: May 25, 2023
Single-Cell Profiling of the Intrinsic Apoptotic Pathway by Mass Cytometry (CyTOF).
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 10, 2022
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells.
Journal: Blood advances
Published: May 31, 2022
PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 08, 2022
Last Updated: 09/26/2026